References

• Abdallah, C. G., Averill, L. A., Akiki, T. J., Raza, M., Averill, C. L., Gomaa, H., Adikey, A., & Krystal, J. H. (2019). The neurobiology and pharmacotherapy of posttraumatic stress disorder. Annual Review of Pharmacology and Toxicology, 59(1), 171–189. https://doi.org/10.1146/ANNUREV-PHARMTOX-010818-021701
   PubMedGoogle Scholar
• Abdallah, C. G., Averill, L. A., & Krystal, J. H. (2015). Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Annals of the New York Academy of Sciences, 1344(1), 66–77. https://doi.org/10.1111/nyas.12718
   PubMedGoogle Scholar
• Abdallah, C. G., Roache, J. D., Gueorguieva, R., Averill, L. A., Young-McCaughan, S., Shiroma, P. R., Purohit, P., Brundige, A., Murff, W., Ahn, K. H., Sherif, M. A., Baltutis, E. J., Ranganathan, M., D’Souza, D., Martini, B., Southwick, S. M., Petrakis, I. L., Burson, R. R., Guthmiller, K. B., … Krystal, J. H. (2022). Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: A double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology, 47(8), 1574–1581. https://doi.org/10.1038/s41386-022-01266-9
   PubMed Web of Science ®Google Scholar
• Aita, S. L., Kondrath, S. R., Owen, T., Borgogna, N. C., & Usset, T. (2023). The status of evidence-based treatments for moral injury syndrome: Review and meta-analysis of randomized controlled trials. Current Treatment Options in Psychiatry, 10(3), 217–233.
   Google Scholar
• Artin, H., Bentley, S., Mehaffey, E., Liu, F. X., Sojourner, K., Bismark, A. W., Printz, D., Lee, E. E., Martis, B., De Peralta, S., Baker, D. G., Mishra, J., & Ramanathan, D. (2022). Effects of intranasal (S)-ketamine on veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series. EClinicalMedicine, 48, Article 101439. https://doi.org/10.1016/J.ECLINM.2022.101439
   PubMedGoogle Scholar
• Asim, M., Wang, B., Hao, B., & Wang, X. (2021). Ketamine for post-traumatic stress disorders and it’s possible therapeutic mechanism. Neurochemistry International, 146, Article 105044. https://doi.org/10.1016/J.NEUINT.2021.105044
   PubMed Web of Science ®Google Scholar
• Begola, M. J., & Schillerstrom, J. E. (2019). Hallucinogens and their therapeutic use: A literature review. Journal of Psychiatric Practice, 25(5), 334–346. https://doi.org/10.1097/PRA.0000000000000409
   PubMed Web of Science ®Google Scholar
• Benish, S. G., Imel, Z. E., & Wampold, B. E. (2008). The relative efficacy of bona fide psychotherapies for treating post-traumatic stress disorder: A meta-analysis of direct comparisons. Clinical Psychology Review, 28(5), 746–758. https://doi.org/10.1016/J.CPR.2007.10.005
   PubMed Web of Science ®Google Scholar
• Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015). The posttraumatic stress disorder checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. Journal of Traumatic Stress, 28(6), 489–498. https://doi.org/10.1002/JTS.22059
   PubMed Web of Science ®Google Scholar
• Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2013). Comprehesnive meta-analysis. Bisostat.
   Google Scholar
• Borgogna, N. C., Owen, T., Aita, S.L. (2024). The absurdity of latent disease model in mental health: 10,130,814 ways to have a DSM-5-TR psychological disorder. Journal of Mental Health, https://doi.org/10.1080/09638237.2023.2278107
   Web of Science ®Google Scholar
• Chen, X., Hou, X., Bai, D., Lane, R., Zhang, C., Canuso, C., Wang, G., & Fu, D. J. (2023). Efficacy and safety of flexibly dosed esketamine nasal spray plus a newly initiated oral antidepressant in adult patients with treatment-resistant depression: A randomized, double-blind, multicenter, active-controlled study conducted in China and USA. Neuropsychiatric Disease and Treatment, 19, 693–707. https://doi.org/10.2147/NDT.S391096
   PubMed Web of Science ®Google Scholar
• Cuijpers, P., & Cristea, I. A. (2015). What if a placebo effect explained all the activity of depression treatments? World Psychiatry, 14(3), 311. https://doi.org/10.1002/WPS.20249
   Web of Science ®Google Scholar
• Dadabayev, A. R., Joshi, S. A., Reda, M. H., Lake, T., Hausman, M. S., Domino, E., & Liberzon, I. (2020). Low dose ketamine infusion for comorbid posttraumatic stress disorder and chronic pain: A randomized double-blind clinical trial. Chronic Stress, 4, 1–9. https://doi.org/10.1177/2470547020981670
   Google Scholar
• Dames, S., Kryskow, P., & Watler, C. (2022). A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression. Frontiers in Psychiatry, 12, 2391. https://doi.org/10.3389/FPSYT.2021.803279
   Web of Science ®Google Scholar
• D’Andrea, D., & Andrew Sewell, R. (2013). Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion. Biological Psychiatry, 74(9), e13–e14. https://doi.org/10.1016/j.biopsych.2013.04.019
   PubMed Web of Science ®Google Scholar
• Davey, J., Turner, R. M., Clarke, M. J., & Higgins, J. P. (2011). Characteristics of meta-analyses and their component studies in the cochrane database of systematic reviews: A cross-sectional, descriptive analysis. BMC Medical Research Methodology, 11(1), 1–11. https://doi.org/10.1186/1471-2288-11-160
   PubMedGoogle Scholar
• de Laportalière, T. T., Jullien, A., Yrondi, A., Cestac, P., & Montastruc, F. (2023). Reporting of harms in clinical trials of esketamine in depression: A systematic review. Psychological Medicine, 53(10), 4305–4315. https://doi.org/10.1017/S0033291723001058
   PubMed Web of Science ®Google Scholar
• Du, R., Han, R., Niu, K., Xu, J., Zhao, Z., Lu, G., & Shang, Y. (2022). The multivariate effect of ketamine on PTSD: Systematic review and meta-analysis. Frontiers in Psychiatry, 13, 1–9. https://doi.org/10.3389/fpsyt.2022.813103
   Web of Science ®Google Scholar
• Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463. https://doi.org/10.1111/J.0006-341X.2000.00455.X
   PubMed Web of Science ®Google Scholar
• Feder, A., Costi, S., Rutter, S. B., Collins, A. B., Govindarajulu, U., Jha, M. K., Horn, S. R., Kautz, M., Corniquel, M., Collins, K. A., Bevilacqua, L., Glasgow, A. M., Brallier, J., Pietrzak, R. H., Murrough, J. W., & Charney, D. S. (2021). A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. American Journal of Psychiatry, 178(2), 193–202. https://doi.org/10.1176/appi.ajp.2020.20050596
   PubMed Web of Science ®Google Scholar
• Feder, A., Norbury, A., Rutter, S., Costi, S., Jha, M., Charney, D., & Murrough, J. (2022). Neural circuitry mechanisms of response to ketamine in PTSD: Preliminary findings. Biological Psychiatry, 91(9), S34–S35. https://doi.org/10.1016/j.biopsych.2022.02.104
   Web of Science ®Google Scholar
• Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., Rot, A. H., Lapidus, M., Wan, K. A. B., Ben, L., Iosifescu, D., & Charney, D. S. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 71(6), 681–688. https://doi.org/10.1001/jamapsychiatry.2014.62
   PubMed Web of Science ®Google Scholar
• Galatzer-Levy, I. R., & Bryant, R. A. (2013). 636,120 ways to have posttraumatic stress disorder. Perspectives on Psychological Science, 8(6), 651–662. https://doi.org/10.1177/1745691613504115
   Web of Science ®Google Scholar
• Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., & Welch, V. A. (2019). Cochrane handbook for systematic reviews of interventions (2nd ed.). Wiley-Blackwell.
   Google Scholar
• Katalinic, N., Lai, R., Somogyi, A., Mitchell, P. B., Glue, P., & Loo, C. K. (2013). Ketamine as a new treatment for depression: A review of its efficacy and adverse effects. Australian and New Zealand Journal of Psychiatry, 47(8), 710–727. https://doi.org/10.1177/0004867413486842
   PubMed Web of Science ®Google Scholar
• Krystal, J. H., Abdallah, C. G., Averill, L. A., Kelmendi, B., Harpaz-Rotem, I., Sanacora, G., Southwick, S. M., & Duman, R. S. (2017). Synaptic loss and the pathophysiology of PTSD: Implications for ketamine as a prototype novel therapeutic. Current Psychiatry Reports, 19(10), 1–11. https://doi.org/10.1007/s11920-017-0829-z
   PubMed Web of Science ®Google Scholar
• Krystal, J. H., Davis, L. L., Neylan, T. C., Raskind, A., Schnurr, M., Stein, P. P., Vessicchio, M. B., Shiner, J. B., Gleason, T. D., & Huang, D. G. (2017). It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: A consensus statement of the PTSD psychopharmacology working group. Biological Psychiatry, 82(7), e51–e59. https://doi.org/10.1016/J.BIOPSYCH.2017.03.007
   PubMed Web of Science ®Google Scholar
• Krystal, J. H., Rosenheck, R. A., Cramer, J. A., Vessicchio, J. C., Jones, K. M., Vertrees, J. E., Horney, R. A., Huang, G. D., & Stock, C. (2011). Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: A randomized trial. JAMA, 306(5), 493–502. https://doi.org/10.1001/JAMA.2011.1080
   PubMed Web of Science ®Google Scholar
• Lakens, D. (2013). Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Frontiers in Psychology, 4, 1–12. https://doi.org/10.3389/fpsyg.2013.00863
   PubMed Web of Science ®Google Scholar
• Marazziti, D., Mucci, F., Tripodi, B., Carbone, M. G., Muscarella, A., Falaschi, V., & Baroni, S. (2019). Emotional blunting, cognitive impairment, bone fractures, and bleeding as possible side effects of long-term Use of SSRIs. Clinical Neuropsychiatry, 16(2), 75–85.
   PubMed Web of Science ®Google Scholar
• Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2022). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28(8), 3243–3256. https://doi.org/10.1038/s41380-022-01661-0
   PubMedGoogle Scholar
• Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., Charney, D. S., & Mathew, S. J. (2013). Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial. American Journal of Psychiatry, 170(10), 1134–1142. https://doi.org/10.1176/appi.ajp.2013.13030392
   PubMed Web of Science ®Google Scholar
• NHLBI. (2021). Study quality assessment tools.
   Google Scholar
• Padala, P. R., Madison, J., Monnahan, M., Marcil, W., Price, P., Ramaswamy, S., Din, A. U., Wilson, D. R., & Petty, F. (2006). Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. International Clinical Psychopharmacology, 21(5), 275–280. https://doi.org/10.1097/00004850-200609000-00005
   PubMed Web of Science ®Google Scholar
• Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Medicine, 18(3), e1003583. https://doi.org/10.1371/JOURNAL.PMED.1003583
   PubMed Web of Science ®Google Scholar
• Phillips, J. L., Norris, S., Talbot, J., Birmingham, M., Hatchard, T., Ortiz, A., Owoeye, O., Batten, L. A., & Blier, P. (2019). Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: A randomized controlled trial. American Journal of Psychiatry, 176(5), 401–409. https://doi.org/10.1176/appi.ajp.2018.18070834
   PubMed Web of Science ®Google Scholar
• Pradhan, B. K., Mitrev, L., Moaddell, R., & Wainer, I. W. (2018). d-Serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: A pilot study. Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics, 1866(7), 831–839. https://doi.org/10.1016/J.BBAPAP.2018.03.006
   PubMed Web of Science ®Google Scholar
• Pradhan, B. K., Wainer, I. W., Moaddel, R., Torjman, M. C., Goldberg, M., Sabia, M., Parikh, T., & Pumariega, A. J. (2017). Trauma interventions using mindfulness based extinction and reconsolidation (TIMBER) psychotherapy prolong the therapeutic effects of single ketamine infusion on post-traumatic stress disorder and comorbid depression: A pilot randomized, placebo-controlled, crossover clinical trial. Asia Pacific Journal of Clinical Trials: Nervous System Diseases, 2(3), 80. https://doi.org/10.4103/2542-3932.211589
   Google Scholar
• Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., Hart, K. L., McFall, M., Mellman, T. A., Reist, C., Romesser, J., Rosenheck, R., Shih, M.-C., Stein, M. B., Swift, R., Gleason, T., Lu, Y., & Huang, G. D. (2018). Trial of prazosin for post-traumatic stress disorder in military veterans. New England Journal of Medicine, 378(6), 507–517. https://doi.org/10.1056/NEJMOA1507598
   PubMed Web of Science ®Google Scholar
• Rauch, S. A. M., & Ruzek, J. (2012). Review of exposure therapy: A gold standard for PTSD treatment victimology view project mindfulness and self-compassion for trauma and PTSD view project. The Journal of Rehabilitation Research and Development, 49(5), 679–688. https://doi.org/10.1682/JRRD.2011.08.0152
   PubMed Web of Science ®Google Scholar
• Riggs, L. M., & Gould, T. D. (2021). Ketamine and the future of rapid-acting antidepressants. Annual Review of Clinical Psychology, 17(1), 207–231. https://doi.org/10.1146/ANNUREV-CLINPSY-072120-014126
   PubMedGoogle Scholar
• Schein, J., Houle, C., Urganus, A., Cloutier, M., Patterson-Lomba, O., Wang, Y., King, S., Levinson, W., Guérin, A., Lefebvre, P., & Davis, L. L. (2021). Prevalence of post-traumatic stress disorder in the United States: A systematic literature review. Current Medical Research and Opinion, 37(12), 2151–2161. https://doi.org/10.1080/03007995.2021.1978417
   PubMed Web of Science ®Google Scholar
• Schnurr, P. P., Chard, K. M., Ruzek, J. I., Chow, B. K., Resick, P. A., Foa, E. B., Marx, B. P., Friedman, M. J., Bovin, M. J., Caudle, K. L., Castillo, D., Curry, K. T., Hollifield, M., Huang, G. D., Chee, C. L., Astin, M. C., Dickstein, B., Renner, K., Clancy, C. P., … Shih, M. C. (2022). Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans: A randomized clinical trial. JAMA Network Open, 5(1), e2136921. https://doi.org/10.1001/JAMANETWORKOPEN.2021.36921
   PubMed Web of Science ®Google Scholar
• Steenkamp, M. M., Litz, B. T., Hoge, C. W., & Marmar, C. R. (2015). Psychotherapy for military-related PTSD: A review of randomized clinical trials. JAMA, 314(5), 489–500. https://doi.org/10.1001/JAMA.2015.8370
   PubMed Web of Science ®Google Scholar
• Stein, M. B., & Simon, N. M. (2021). Ketamine for PTSD: Well, isn’t that special. The American Journal of Psychiatry, 178(2), 116–118. https://doi.org/10.1176/APPI.AJP.2020.20121677
   PubMed Web of Science ®Google Scholar
• Varker, T., Watson, L., Gibson, K., Forbes, D., & O’Donnell, M. L. (2021). Efficacy of psychoactive drugs for the treatment of posttraumatic stress disorder: A systematic review of MDMA, ketamine, LSD and psilocybin. Journal of Psychoactive Drugs, 53(1), 85–95. https://doi.org/10.1080/02791072.2020.1817639
   PubMed Web of Science ®Google Scholar
• Von Hippel, P. T. (2015). The heterogeneity statistic I2 can be biased in small meta-analyses. BMC Medical Research Methodology, 15(1), 35. https://doi.org/10.1186/S12874-015-0024-Z
   PubMedGoogle Scholar
• Wampold, B. E. (2015). How important are the common factors in psychotherapy? An update. World Psychiatry, 14(3), 270–277. https://doi.org/10.1002/WPS.20238
   PubMed Web of Science ®Google Scholar
• Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018). Addressing the side effects of contemporary antidepressant drugs: A comprehensive review. Chonnam Medical Journal, 54(2), 101–112. https://doi.org/10.4068/cmj.2018.54.2.101
   PubMedGoogle Scholar
• Weathers, F. W., Bovin, M. J., Lee, D. J., Sloan, D. M., Schnurr, P. P., Kaloupek, D. G., Keane, T. M., & Marx, B. P. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383–395. https://doi.org/10.1037/pas0000486
   PubMed Web of Science ®Google Scholar
• Weiss, D. S. (2004). The impact of events scale-revised. In J. P. Wilson & M. K. Terence (Eds.), Assessing psychological trauma and PTSD (2nd ed., pp. 168–189). Guilford Press.
   Google Scholar
• Whittaker, E., Dadabayev, A. R., Joshi, S. A., & Glue, P. (2021). Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders. Therapeutic Advances in Psychopharmacology, 11, 204512532110567. https://doi.org/10.1177/20451253211056743
   Web of Science ®Google Scholar
• Yousefifard, M., Askarian-Amiri, S., Rafiei Alavi, S. N., Sadeghi, M., Saberian, P., Baratloo, A., & Talebian, M. T. (2020). The efficacy of ketamine administration in prehospital pain management of trauma patients; a systematic review and meta-analysis. Archives of Academic Emergency Medicine, 8, e1. https://doi.org/10.22037/aaem.v8i1.479
   PubMedGoogle Scholar
• Zakzanis, K. K. (2001). Statistics to tell the truth, the whole truth, and nothing but the truth: Formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists, 16(7), 653–667. https://doi.org/10.1093/arclin/16.7.653
   PubMed Web of Science ®Google Scholar